These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 33963478)
41. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting. Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655 [TBL] [Abstract][Full Text] [Related]
42. A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses' Perspective. Hussain R; Hassali MA; Ur Rehman A; Muneswarao J; Atif M; Babar ZU Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32349339 [TBL] [Abstract][Full Text] [Related]
43. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report. Hariraj V; Aziz Z Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567 [TBL] [Abstract][Full Text] [Related]
44. Pharmacovigilance in China: development and challenges. Zhao Y; Wang T; Li G; Sun S Int J Clin Pharm; 2018 Aug; 40(4):823-831. PubMed ID: 30051225 [TBL] [Abstract][Full Text] [Related]
45. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583 [TBL] [Abstract][Full Text] [Related]
46. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department. Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501 [TBL] [Abstract][Full Text] [Related]
47. [ADR/AE early warning analysis of Shujin Jianyao Pills based on spontaneous reporting system]. Zhang C; Li PP; Wang LX; Xie YM; Li L Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3533-3538. PubMed ID: 32893541 [TBL] [Abstract][Full Text] [Related]
48. Kounis syndrome: A retrospective analysis of individual case safety reports from the international WHO database in pharmacovigilance . Orion K; Mack J; Kullak-Ublick GA; Weiler S Int J Clin Pharmacol Ther; 2019 May; 57(5):240-248. PubMed ID: 30900982 [TBL] [Abstract][Full Text] [Related]
49. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year. Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797 [TBL] [Abstract][Full Text] [Related]
50. Detection of adverse drug reactions through the minimum basic data set. Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432 [TBL] [Abstract][Full Text] [Related]
51. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Herdeiro MT; Ribeiro-Vaz I; Ferreira M; Polónia J; Falcão A; Figueiras A Drug Saf; 2012 Aug; 35(8):655-65. PubMed ID: 22788235 [TBL] [Abstract][Full Text] [Related]
52. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda. Katusiime B; Semakula D; Lubinga SJ Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036 [TBL] [Abstract][Full Text] [Related]
53. Risk factors of early adverse drug reactions with phenytoin: A prospective inpatient cohort. Uribe-San-Martín R; Ciampi E; Uslar W; Villagra S; Plaza J; Godoy J; Mellado P Epilepsy Behav; 2017 Nov; 76():139-144. PubMed ID: 28927713 [TBL] [Abstract][Full Text] [Related]
54. Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China. Fang H; Lin X; Zhang J; Hong Z; Sugiyama K; Nozaki T; Sameshima T; Kobayashi S; Namba H; Asakawa T BMC Pharmacol Toxicol; 2017 Jun; 18(1):49. PubMed ID: 28651624 [TBL] [Abstract][Full Text] [Related]
55. Adverse drug reaction related to drug shortage: A retrospective study on the French National Pharmacovigilance Database. Bourneau-Martin D; Babin M; Grandvuillemin A; Mullet C; Salvo F; Singier A; Cellier M; Fresse A; de Canecaude C; Pietri T; Drablier G; Geniaux H; Lagarce L; Laroche ML; Briet M; Br J Clin Pharmacol; 2023 Mar; 89(3):1080-1088. PubMed ID: 36177609 [TBL] [Abstract][Full Text] [Related]
56. Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions. Li R; Curtis K; Zaidi STR; Van C; Thomson A; Castelino R Expert Opin Drug Saf; 2021 Oct; 20(10):1267-1274. PubMed ID: 34077311 [No Abstract] [Full Text] [Related]
57. Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients. Zheng L; Jin HB; Guan YY; Yang J BMC Pharmacol Toxicol; 2022 Aug; 23(1):62. PubMed ID: 35948985 [TBL] [Abstract][Full Text] [Related]
58. Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. Kaguelidou F; Beau-Salinas F; Jonville-Bera AP; Jacqz-Aigrain E Br J Clin Pharmacol; 2016 Oct; 82(4):1058-68. PubMed ID: 27276109 [TBL] [Abstract][Full Text] [Related]
59. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Cliff-Eribo KO; Sammons H; Choonara I Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085 [TBL] [Abstract][Full Text] [Related]
60. Are non-serious adverse reactions to psychiatric drugs really non-serious? Pozzi M; Bertella S; Cattaneo D; Molteni M; Perrone V; Carnovale C; Antoniazzi S; Clementi E; Radice S J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):394-400. PubMed ID: 23952186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]